---
title: "Iranian Missile Hits Haifa Refinery, Israeli Media Reports"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279817340.md"
description: "An Iranian missile reportedly struck the Haifa refinery in Israel, according to Israeli media sources. The incident did not result in any casualties. The missile attack highlights ongoing tensions in the region, with further details about the incident and its implications yet to be disclosed by official sources."
datetime: "2026-03-19T15:26:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279817340.md)
  - [en](https://longbridge.com/en/news/279817340.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279817340.md)
generator: "portal-rs"
---

# Iranian Missile Hits Haifa Refinery, Israeli Media Reports

An Iranian missile reportedly struck the Haifa refinery in Israel, according to Israeli media sources. The incident did not result in any casualties. According to Jin10, the missile attack highlights ongoing tensions in the region. Further details about the incident and its implications are yet to be disclosed by official sources.

### Related Stocks

- [ISRL.US](https://longbridge.com/en/quote/ISRL.US.md)
- [ISRA.US](https://longbridge.com/en/quote/ISRA.US.md)
- [PPA.US](https://longbridge.com/en/quote/PPA.US.md)

## Related News & Research

- [3 US Financial Stocks Benefiting From Higher Interest Rates Right Now](https://longbridge.com/en/news/298959218.md)
- [Worldwide NFT signs LOI to acquire RedTrace Technologies](https://longbridge.com/en/news/299057672.md)
- [US., EM equities appeal even as global rates march higher](https://longbridge.com/en/news/298993744.md)
- [LXEO: Lead gene therapy programs advance toward pivotal milestones with strong efficacy and commercial focus](https://longbridge.com/en/news/299076198.md)
- [HIV charities lament NICE snub for Gilead’s twice-yearly lenacapavir](https://longbridge.com/en/news/298763671.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**